» Articles » PMID: 17964573

Role of NAD Binding and Catalytic Residues in the C-terminal Binding Protein Corepressor

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2007 Oct 30
PMID 17964573
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

CtBP corepressor proteins potentiate the activity of many metazoan transcriptional repressors. These proteins are homologous to prokaryotic D-2-hydroxyacid dehydrogenases, possessing an NAD/NADH binding fold and conserved active site residues. When expressed in Drosophila, a catalytic site mutant retains biological activity, however, we find that an NAD binding mutant lacks biological activity. The NAD mutant, similar to a dimerization mutant, is expressed at low levels, indicating that binding of NAD/NADH may affect CtBP stability. These data support the idea that the ancestral dehydrogenase activity is not required for CtBP function, and NAD binding may play a regulatory, rather than catalytic, role.

Citing Articles

NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).

Nichols J, Schiffer C, Royer Jr W J Biol Chem. 2021; 296:100351.

PMID: 33524397 PMC: 7949142. DOI: 10.1016/j.jbc.2021.100351.


Cryo-EM structure of CtBP2 confirms tetrameric architecture.

Jecrois A, Dcona M, Deng X, Bandyopadhyay D, Grossman S, Schiffer C Structure. 2020; 29(4):310-319.e5.

PMID: 33264605 PMC: 9159756. DOI: 10.1016/j.str.2020.11.008.


Adaptive Evolution Targets a piRNA Precursor Transcription Network.

Parhad S, Yu T, Zhang G, Rice N, Weng Z, Theurkauf W Cell Rep. 2020; 30(8):2672-2685.e5.

PMID: 32101744 PMC: 7061269. DOI: 10.1016/j.celrep.2020.01.109.


NAD-linked mechanisms of gene de-repression and a novel role for CtBP in persistent adenovirus infection of lymphocytes.

Dickherber M, Garnett-Benson C Virol J. 2019; 16(1):161.

PMID: 31864392 PMC: 6925507. DOI: 10.1186/s12985-019-1265-y.


Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.

Dcona M, Damle P, Zarate-Perez F, Morris B, Nawaz Z, Dennis M Mol Pharmacol. 2019; 96(1):99-108.

PMID: 31036695 PMC: 6560337. DOI: 10.1124/mol.118.114363.